Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Related Posts
Sumner JA, Dennis PA, Alvarez CA, Perkins A, Beckham JC, Ebrahimi R. Antidepressant Medication Prescription and Incident Cardiovascular Disease in Women Veterans. J Clin Psychiatry.[...]
Menuet C, Ben-Tal A, Linossier A, Allen AM, Machado BH, Moraes DJA, Farmer DGS, Paterson DJ, Mendelowitz D, Lakatta EG, Taylor EW, Ackland GL, Zucker[...]
Zhou Z, Moore TM, Strumwasser AR, Ribas V, Iwasaki H, Morrow N, Ma A, Tran PH, Wanagat J, de Aguiar Vallim TQ, Clifford B, Zhang[...]